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Background: Inflammation plays a central role in chronic diseases occurring in the contemporary society. The
health benefits of omega-3 (n-3) fatty acids (FAs), mostly eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA), have been reported. However, their mechanisms of action are poorly understood. We explored dose and
time effects of EPA, DHA, and a mixture of EPA + DHA on the expression of inflammatory genes in stimulated
macrophages.
Methods: Lipopolysaccharide was used to stimulate human THP-1 macrophages. Cells were incubated in different
conditions in the presence of n-3 FAs and LPS, and mRNA levels of inflammatory genes were measured by real-time
PCR. Cytokine levels in culture media were measured.
Results: The mixture of EPA + DHA had a more effective inhibitory effect than either DHA or EPA alone, DHA being
more potent than EPA. For both EPA and DHA, 75 μM of FAs had a more important anti-inflammatory effect than 10 or
50 μM. For gene expression, EPA had the greater action during the post-incubation (after LPS treatment) condition
while DHA and EPA + DHA were more potent during the co-incubation (n-3 FAs and LPS). Cytokine concentrations
decreased more markedly in the co-incubation condition.
Conclusions: These results suggest that in stimulated macrophages, expression levels of genes involved in inflammation
are influenced by the dose, the type of n-3 FAs, and the time of incubation.
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Inflammation is a biological response to harmful chem-
ical or physical stimuli. The purpose of an acute resolv-
ing inflammatory response is to protect the human body
from damage and to re-establish homeostasis [24].
Several conditions such as inflammatory bowel disease,
cardiovascular diseases (CVD), Alzheimer’s disease, or
cancers are caused by a persistent inflammation and
their prevalence increase due to inappropriate responses
arising in a chronic manner along with them [9, 20].
Fatty acids (FAs) are carboxylic acids with a variable
number of carbon atoms, building a hydrocarbon chain,
which finishes with carboxyl and methyl groups.* Correspondence: marie-claude.vohl@fsaa.ulaval.ca
1Institute of Nutrition and Functional Foods (INAF), Laval University, Pavillon
des Services, 2440 Hochelaga Blvd, Québec, Québec, Canada
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zePolyunsaturated FAs (PUFAs) contain more than one
double bond in their backbone. Omega-6 (n-6) and
omega-3 (n-3) are the two main families of FAs. Linoleic
acid (LA) and alpha-linolenic acid (ALA) are, respect-
ively, the precursors of n-6 and n-3 FAs. These FAs are
called essential because they cannot be produced by the
body and must be provided by the diet. The main FAs
derived from n-6 FAs is arachidonic acid producing
rather pro-inflammatory eicosanoids. FAs derived from
ALA, namely eicosapentaenoic acid (EPA; 20:5n − 3) and
docosahexaenoic acid (DHA; 22:6n − 3), produce eicosa-
noids with a less inflammatory profile [4]. Human being
synthetizes EPA and DHA from their dietary precursor
ALA at a very low rate. This makes dietary intake of
EPA and DHA a more efficient source for their assimila-
tion. In fact, their availability are increased when theyle is distributed under the terms of the Creative Commons Attribution 4.0
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erel, and salmon or in fish oil supplements [19].
n-3 FAs, particularly EPA and DHA, have been proven
to exert beneficial effects on health. Over the past
decades, mechanisms by which EPA and DHA impact
inflammation have been investigated, demonstrating an
improvement of cardiovascular health [10, 14], inflam-
mation status [5], or cancer progression [3, 12] after
their consumption.
Despite significant advances on health benefits associ-
ated with n-3 FAs, the dose needed to provide health
benefits, the best window of time to consume them to
fight efficiently against inflammation, and the mecha-
nisms of action in preventing inflammation-related dis-
eases are still unclear. Thus, the aim of the present study
was to investigate the effect of 10, 50, and 75 μM EPA,
DHA, and a mixture of EPA + DHA on the expression
of inflammatory genes in stimulated THP-1 macro-
phages. The impact of the condition of incubation (pre-
incubation, co-incubation, post-incubation) with n-3 FAs
relative to macrophage stimulation was also evaluated.
Methods
Reagents and cell lines
Cell culture media, Roswell Park Memorial Institute (RPMI)
1640 medium, fetal bovine serum (FBS), penicillin and
streptomycin media supplements, phorbol 12-myristate 13-
acetate (PMA), and dimethyl sulfoxide (DMSO) were
purchased from Thermo Scientific (Walthman, USA). Lipo-
polysaccharide (LPS) from Escherichia coli 0111:B4 (refer-
ence L2630) was purchased from Sigma (Saint Louis, USA).
Phosphate-buffered saline (PBS) solution was obtained from
Life Technologies (Burlington, Canada). EPA, DHA, and re-
agents for reverse transcription were obtained from Applied
Biosystems (Oakville, Canada).
Cell culture and fatty acid treatment
The human THP-1 cell line, an acute monocytic
leukemia cell line (American Type Culture Collection
(ATCC), Rockville, MD, USA), was cultured in RPMI
1640 media supplemented with penicillin (100 U/ml)
and streptomycin (100 μM/ml), 10% FBS at 37 °C in a
5% CO2 incubator. Differentiation of monocytes into
macrophages was induced with PMA. 9 × 105 cells per
ml were seeded into six-well plates, with 200 nM of
PMA for 72 h. Then, non-attached cells were removed
by aspiration, adherent cells were washed three times
with PBS, and then, cells were ready for experiments.
The cells were incubated in different conditions: (1) in
the post-incubation condition, the macrophages were
stimulated during 18 h by LPS, before the addition of n-
3 FAs for 24 h; (2) in the co-incubation condition, the
cells were incubated during 24 h with LPS and n-3 FAs
at the same time; (3) finally, in the pre-incubationcondition, the macrophages were incubated during 24 h
into n-3 FAs and then stimulated during 18 h by an
addition of LPS.
n-3 FAs and LPS preparation
All treatments were performed in triplicate, and the en-
tire experiment was replicated independently three
times. LPS was dissolved in PBS and diluted to a final
concentration of 10 ng/ml prior to treatment. Stock so-
lutions of FAs (EPA-DMSO 33 × 104 μM and DHA-
DMSO 76 × 104 μM) prepared in serum-free RPMI 1640
medium were diluted in culture medium to obtain 10,
50, and 75 μM concentrations. Fresh FAs and LPS were
prepared before every experiment from the frozen stock
solution. The cells were thereafter incubated with LPS
and EPA, DHA, or EPA + DHA (ratio 1:1) for 24 h.
Controls in this experiment were THP-1 cells incubated
with the vehicle, DMSO, and LPS.
Cell proliferation and cytotoxicity assay
A viability test was performed to exclude cytotoxicity of
EPA, DHA, and EPA + DHA concentrations used. Briefly,
cell cytotoxicity was assessed by measuring the activity of
mitochondrial dehydrogenase. 3-(4,5-Dimethyl-2-thiazol)-
2,5-diphenyl-2h-tetrazolium bromide (MTT) reagent was
used. After incubation at 37 °C for 1 h, the absorbance at
490 nm was assayed using an ELISA plate reader
(Biotech).
RNA isolation and quantitative real-time PCR
After 24 h, following the protocol provided, total RNA
was extracted using RNeasy Mini Kit (Qiagen). RNA qual-
ity and integrity were tested on 1.5% agarose gel electro-
phoresis with ethidium bromide staining. Absorption
spectroscopy at 260/280 was used to determine RNA con-
centrations. Then, complementary DNA (cDNA) was pro-
duced from RNA using High Capacity Transcription Kit
(Applied Biosystems). The expression of several inflam-
matory genes (SOCS1, TNFAIP3, TNFA, IL1B, IL6,
MCP1, PTGS2) was assessed using real-time PCR. PCR
samples were normalized against 18S gene expression.
Applied Biosystems provided primers and TaqMan®
probes (Table 1).
Cytokine measurements
Cytokines, TNFA, IL1B, IL6, and MCP1, were assessed
in collected media, using the Bio-Plex Pro Human
Chemokine kit (Bio-Rad Laboratories Canada Ltd.,
Mississauga, ON, Canada) according to the manufac-
turer’s instructions.
Statistical analyses
Statistical analyses were done using SAS software (ver-
sion 9.2). Experimental results were reported as mean ± SE.



















Allam-Ndoul et al. Genes & Nutrition  (2017) 12:7 Page 3 of 8Analysis of variance was used to compare between
group means. A significant overall F test was followed
by post hoc comparisons using the LS means procedure.
The level of significance was defined at P < 0.05 for all.
Results
Cytotoxicity assay
The effect of EPA, DHA, and EPA + DHA on THP-1
macrophage viability was performed using the MTT
assay. After 24-h incubation of the cells with 10, 50,
and 75 μM EPA, DHA, and EPA + DHA, the test was
done. All concentrations of each n-3 FA investigated
did not have any effect on cell viability (data not
shown).
Influence of EPA, DHA, and EPA + DHA on inflammatory
gene expression
The cells were cultivated in three conditions. First, the
macrophages were incubated in FAs before being stimu-
lated (pre-incubation). In the second condition, inflam-
mation and treatment with n-3 FAs were done at the
same time (co-incubation). Finally, in the last condition,
inflammation was triggered before adding the FAs (post-
incubation). In the presence of LPS stimulation, there
was a global increase of gene expression levels of inflam-
matory genes compared with the control (dotted line,
Fig. 1). After the addition of n-3 FAs in the culture
medium, a global suppression of IL6, TNFA, IL1B,
MCP1, TNFAIP3, and PTGS2 expression was seen. The
effect was more pronounced with the mixture EPA +
DHA than with either EPA or DHA alone. Theincubation of cells with n-3 FAs had different effects de-
pending on the FAs. Except for MCP1 for which the
post-incubation and co-incubation conditions had the
same effect, the post-incubation with EPA was more effi-
cient on reducing IL6, TNFA, IL1B, and TNFAIP3 gene
expression than the co-incubation and the pre-
incubation. For treatment with either DHA or the mix-
ture EPA + DHA, the co-incubation of THP-1 cells in
these FAs was more potent than the pre- and post-
incubation for all the studied genes. A dose effect was
observed on gene expression levels; incubation of cells
in 75 μM of any FAs decreased their expression more
efficiently than incubation in 10 and 50 μM. LPS stimu-
lation increased SOCS1 expression. A regulation of this
gene was seen only with 75 μM of each n-3 FA, which
further increased SOCS1 expression. No condition-
dependant modulation of SOCS1 was seen.
Influence of EPA, DHA, and EPA + DHA on cytokine secretion
Since the results obtained in the co-incubation and the
post-incubation conditions were the most interesting,
cytokine measurements were done for these two
conditions.
In the LPS-stimulated condition, compared to the con-
trol condition (LPS−), there was an increased production
of cytokines (Fig. 2). When EPA, DHA, or the mixture
EPA + DHA was added to the cultured medium, for
each cytokine, a decreased secretion was observed. This
diminution was more important in the co-incubation
than in the post-incubation condition. A dose effect was
also noted; 75 μM of each n-3 FA decreased cytokine
concentrations more effectively than 10- and 50-μM
doses. FA-specific effects were also seen. DHA and EPA +
DHA downregulated cytokine secretion more efficiently
than EPA. For IL1B and IL6, the co-incubation with DHA
and EPA + DHA restored secretion back to the basal level.
This phenomenon was not observed in cells incubated
with EPA.
Discussion
Because of the health benefits associated with DHA
and EPA, several international agencies and organiza-
tions have put together recommendations for EPA
and DHA supplementation and for fish consumption
[10]. This initiative enabled not only health promo-
tion but also the reduction of the risk of several
chronic inflammatory diseases [3, 23]. Although much
has been learn about n-3 FAs, many questions re-
main, including the dose-response effect on clinical
outcomes as well as the differential effects on health
of EPA and DHA.
The objective of the present study was to investigate
the effect of different concentrations of EPA, DHA, and
EPA + DHA on inflammatory markers, in stimulated
Fig. 1 Influence of n-3 FAs on gene expression. The total RNA was
extracted using RNeasy Mini, then cDNA was produced from the RNA.
The expression of SOCS1, TNFAIP3, TNFA, IL1B, IL6, MCP1, and PTGS2 was
assessed using real-time PCR. PCR samples were normalized against
18S gene expression. Gene expression was measured under three
conditions. a, b, cRepresents the differences (P≤ 0.05) between each of
these conditions (pre-incubation [black bars], co-incubation [gray bars],
and post-incubation [white bars]). 1P≤ 0.05 represents the difference
between different concentrations relative to LPS+ within the same
condition; 2P ≤ 0.05 represents the difference between different
concentrations relative to 10 μM within the same condition; and
3P ≤ 0.05 represents the difference between different concentrations
relative to 50 μM within the same condition
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DHA are associated with a lower risk of inflammatory
diseases [7]. Their health effects are usually studied as a
sum or combination. Thus, little is known about the po-
tential health effect of EPA compared to DHA. Never-
theless, few studies have shown EPA- or DHA-specific
effects on inflammation. Gorjao and collaborators re-
ported different effects of EPA and DHA on endothelial
cells, insulin-secreting cells, and leukocyte function [8].
In a study on RAW 264.7 macrophages, Honda et al.
demonstrated that EPA and DHA attenuated cell inflam-
matory activities and more importantly that their re-
spective effect changed in potency depending on the
investigated cytokines (IL6 and TNFA) [11]. Finally, an
investigation of the effect of EPA and DHA on THP-1
macrophages showed that EPA and DHA had a differen-
tial effect on cytokine transcription [17]. It is important
to further understand the specific effect of n-3 FAs on
inflammatory mechanisms and to know whether they
have complementary, shared, or divergent effects. A pre-
vious study by our research group [2] investigated the
effect of 50 and 10 μM EPA, DHA, and EPA + DHA on
non-stimulated macrophages. This study firstly showed
that in non-inflammatory conditions, EPA and DHA had
a varying effect on the expression of inflammatory genes
and that the anti-inflammatory effect was dose-
dependent [2].
In the present study, our ultimate goal was to investi-
gate the anti-inflammatory effects of n-3 FAs in inflamed
cells. In this perspective, the current study investigated
the effect of EPA, DHA, and EPA + DHA on stimulated
THP-1 macrophages. n-3 FA effects were tested on
seven genes involved in inflammation. An incubation of
these macrophages into 100 ng/ml LPS for 18 h allowed
mimicking an inflammatory state. Stimulation with LPS
increased expression levels of inflammatory genes.
The combination of EPA + DHA (1:1) had a more po-
tent anti-inflammatory action than DHA and EPA alone,
DHA being a better inhibitor of the studied gene expres-
sion than EPA. This implies that giving a mixture of EPA +
DHA (1:1) seems to have the best anti-inflammatory effect.
Fig. 2 (See legend on next page.)
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Fig. 2 Influence of n-3 FAs on cytokine secretion. TNFA, IL1B, IL6, and MCP1 were assessed in collected media of cell cultures. a, bRepresents the
differences (P ≤ 0.05) between each condition (co-incubation [gray bars] and post-incubation [white bars]). 1P ≤ 0.05 represents the difference
between different concentrations relative to LPS+ within the same condition; 2P ≤ 0.05 represents the difference between different concentrations
relative to LPS− within the same condition; 3P ≤ 0.05 represents the difference between different concentrations relative to 10 μM within the
same condition; and 4P≤ 0.05 represents the difference between different concentrations relative to 50 μM within the same condition
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50 μM. A treatment of T cells with 12.5 μM EPA or DHA
during 24 h was done by Verlengia and collaborators [22].
Using the microarray technique, the expression of specific
selected genes involved in cytokine production, cell pro-
duction, signal transduction, and apoptosis was changed.
DHA increased the expression of 62% of the studied genes
against 33% for EPA. In Raji cells which were treated in
the same conditions, 25.9% of the studied genes were reg-
ulated by EPA against 8.4% by DHA. Only 3% of the genes
were regulated by the two n-3 FAs [22]. These results sug-
gest that molecular mechanisms responsible for the mod-
ulatory effect of EPA and DHA on T lymphocytes are
different and that DHA regulated a bigger proportion of
studied genes. In line with different modulatory effects of
EPA and DHA revealed by us and others, an effect of n-3
FAs on heart rate mediated by DHA rather than EPA was
previously demonstrated in a supplementation study
among humans [15]. High heart rate (HR) has long been
associated with CVD morbidity in epidemiological studies.
It has been proven that fish oil intake reduced HR mostly
in individuals with a high baseline HR and when taken for
a long intervention period. In fact, DHA alone (2.8 g/day)
diminished HR by 7% in post-menopausal women and
DHA but not EPA reduced HR by 3.5 beats per minute
and 2.2 beats per minute, respectively, in hyperlipidemic
and healthy males [15].
Regarding cytokine production, it was mostly inhibited
with the mixture of EPA + DHA. This inhibition was
more pronounced than the one observed with either
DHA or EPA alone, DHA being more efficient than
EPA. Weldon et al. investigated the action of n-3 FAs on
cytokine expression in THP-1 macrophages [17]. Pre-
treatment with 100 μM EPA and DHA decreased LPS-
stimulated THP-1 cell secretion of TNFA, IL1B, and IL6
compared to control. Even though the effect of the mix-
ture of EPA + DHA was not investigated, the effect of
DHA was more important than the one observed with
EPA. Similar results were obtained when a lower dose
was used, 25 μM DHA decreased the production of IL6
and IL1B more potently than EPA in LPS-stimulated
THP-1 macrophages. A similar observation has been re-
ported after addition of EPA and DHA to the culture
media of RAW 264.7 macrophages [11]. It must also be
noted that in the present study, n-3 FAs decreased IL6
secretion to a greater extent than other cytokines.This corroborates the fact that anti-inflammatory effects
of n-3 FAs were cytokine specific rather than global.
To our knowledge, only one study has been designed
to provide a head-to-head comparison of the effect of
EPA and DHA on inflammation markers as a primary
outcome. Allaire and collaborators provided 2.7 g/day of
EPA and DHA for 10 weeks to healthy people with ab-
dominal obesity. The group which had DHA supplement
had a greater reduction of plasma IL8 levels and greater
increase of adiponectin concentration [1].
The present study showed that in inflammatory condi-
tions, DHA has a better anti-inflammatory effect than
EPA. It also showed that the mixture EPA/DHA at a 1:1
ratio more efficiently inhibits inflammation. In human sub-
jects, n-3 FAs have been shown to modulate inflammation-
related conditions such as hypertension, dyslipidemia, or
insulin resistance [4]. However, it should be noted that, up
to now, most trials have not considered that the relative
proportion of EPA and DHA may influence the results.
This phenomenon might, at least in part, explain the
relative controversy on the beneficial effect of n-3 FAs on
several conditions. Luis and collaborators [13] have investi-
gated on Wistar Kyoto rats the effect of a supplementation
with different ratios of EPA + DHA on markers of CVD
and oxidative stress. EPA + DHA at a 1:1 ratio triggered
the most important improvement of the risk factor for type
2 diabetes and reduction of oxidative stress. It is important
to point out the fact that in most studies, supplements
used have a greater proportion of EPA than DHA. Since
DHA appears to have a more important anti-inflammatory
action, it might be interesting to reconsider their ratio in
supplements, at least for inflammatory diseases.
At the present time, there is no consensus on the ideal n-
3 FA intake. Nutritional guidelines have been set by several
governments (France, Belgium, Canada) and health organi-
zations (Food and Agriculture Organization, American
Dietetic Association) [21]. For instance, the American
Heart Association (AHA) recommends that all adults eat
fish at least twice a week, which provides 500 mg n-3 FAs/
day. It is also recommended for people with documented
coronary heart diseases to consume 1 g EPA and DHA/day
for secondary prevention [6]. Mozaffarian and collaborators
recently reviewed facts concerning EPA and DHA possible
shared or complementary effects [16]. In human and ani-
mal studies, EPA and DHA reduced platelet aggregation,
modulate inflammation, and lower plasma triglyceride
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DHA increases high-density lipoprotein particles, favors the
proportion of large low-density lipoprotein, and causes
stronger TG-lowering effects. Mozaffarian et al. concluded
that EPA and DHA have complementary and shared bene-
fits. In a study led by Robinson et al., 3T3-L1 adipo-
cytes were incubated in 125 μM of several fatty acids
among which are EPA and DHA. Results have shown
that DHA increased cellular adiponectin mRNA and se-
creted adiponectin protein to a greater extent (40%
more, P < 0.05) than EPA [18].
Unfortunately, scientific evidences are still lacking to
make quantitative recommendation about the ratio and
the dose of EPA and DHA that should be taken to prevent
inflammatory diseases. However, it is known that n-3 FAs
have anti-inflammatory effects and thus their consump-
tion should be favored. Additional experimental, clinical,
and observational investigations are necessary to better
understand the complementary and shared effects of EPA
and DHA on various clinical outcomes.
A dose effect was obvious for the studied genes;
75 μM of each FA had a stronger anti-inflammatory
effect than 10 and 50 μM. It must be noted that a de-
crease of the expression of all genes except for SOCS1
was seen after the addition of 75 μM n-3 FAs. SOCS1
gene expression was increased. This gene encodes for a
suppressor of cytokine signaling. This result suggests
that 75 μM but not 10 or 50 μM of EPA, DHA, or EPA
+ DHA was able to increase SOCS1 expression. SOCS1
being an anti-inflammatory gene, here again, a protective
effect of n-3 FAs is showed.
We tested the effect of three different concentrations of
each n-3 FA in three different cell culture conditions. In
the first condition, the macrophages were incubated in
FAs before being stimulated (pre-incubation); in the sec-
ond, the inflammation and the treatment with n-3 FAs
were done at the same time (co-incubation); and in the
last condition, inflammation was triggered before adding
the FAs (post-incubation). In the post-incubation condi-
tion, the anti-inflammatory effect of EPA was greater for
IL6, IL1B, TNFA, and TNFAIP3. As far as MCP1 was con-
cerned, the post- and co-incubation had the same effect.
EPA + DHA had the best anti-inflammatory effect during
the co-incubation for all genes except for SOCS1 where
no differences were observed between each condition.
Concerning cytokine secretion, the co-incubation seems
to be the better condition for EPA, DHA, and EPA +
DHA. Globally, findings from gene expression and cyto-
kine production suggest that according to the inflamma-
tory environment, the action of each n-3 FA could be
different. Thus, EPA seems to have a greater anti-
inflammatory effect on a situation where an inflammatory
state is already present; this can be associated to a reso-
lution of inflammation. DHA and the mixture EPA + DHAhave a more potent action when they were added at the
same time with LPS. This suggests that starting to take
EPA and DHA at the same moment with the installation of
inflammation might bring out their best anti-inflammatory
effects. Even if the anti-inflammatory effect of n-3 FAs on
the pre-incubation condition is the less important, a dose
effect does exist. It suggests that the protective effect of n-3
FAs among healthy subjects might be visible but less obvi-
ous than the one observed among people with pre-existing
inflammatory conditions. Current recommendations con-
cerning the consumption of n-3 FAs are available not only
as primary prevention of healthy people but also as second-
ary prevention for people suffering of coronary heart dis-
ease or having high TG levels. Human studies investigating
the impact of n-3 FA intake against non-CVD were unfor-
tunately not consistent with the data collected in pre-
clinical studies. This is why consensus recommendation
has not yet been made regarding the possible curative
effects of these FAs or their ability to prevent inflam-
matory disorders. Further investigations are needed to
build more precise recommendations which would
take into account the body inflammatory state, the
best n-3 FAs, and the dose to provide in different in-
flammatory states.
Conclusions
The n-3 FAs do not have the same anti-inflammatory ef-
fect, and depending on the inflammatory state, their action
can be different. This observation adds to the complexity
concerning the dose and ratio of n-3 FAs for optimal
health benefits. In fact, their action seems to depend on
their respective dose when used alone, the ratio of each of
them when used in combination, and also the inflamma-
tory environment at the time of their consumption.
Abbreviations
ALA: Alpha-linolenic acid; DHA: Docosahexaenoic acid; DMSO: Dimethyl
sulfoxide; EPA: Eicosapentaenoic acid; FAs: Fatty acids; FBS: Fetal bovine
serum; LA: Linoleic acid; LPS: Lipopolysaccharide; n-3: Omega-3; n-6: Omega-6;
PMA: Phorbol 12-myristate 13-acetate; PUFAs: Polyunsaturated FAs;
RNA: Ribonucleic acid; RPMI: Roswell Park Memorial Institute
Acknowledgements
The authors would like to acknowledge the contribution of Alain Houde for
the technical assistance.
Funding
This work was supported by a grant from the Natural Sciences and
Engineering Research Council of Canada (grant number: 48031–2012).
Availability of data and materials
Not applicable
Authors’ contributions
BA-N and M-CV conceived and designed the experiments. BA-N and FG
analyzed the data. BA-N, M-CV, and OB interpreted the data. BA-N wrote the
paper. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Allam-Ndoul et al. Genes & Nutrition  (2017) 12:7 Page 8 of 8Consent for publication
Not applicable
Ethics approval and consent to participate
Not applicable
Author details
1Institute of Nutrition and Functional Foods (INAF), Laval University, Pavillon
des Services, 2440 Hochelaga Blvd, Québec, Québec, Canada. 2Laboratory of
Molecular Pharmacology, CHU de Québec Research Center, 2705 Laurier
Blvd, Québec, Québec G1V 4G2, Canada.
Received: 26 July 2016 Accepted: 23 January 2017
References
1. Allaire J, Couture P, Leclerc M, Charest A, Marin J, Lepine MC, Talbot D,
Tchernof A, Lamarche B. A randomized, crossover, head-to-head
comparison of eicosapentaenoic acid and docosahexaenoic acid
supplementation to reduce inflammation markers in men and women: the
Comparing EPA to DHA (ComparED) Study. Am J Clin Nutr. 2016;104:280–7.
2. Allam-Ndoul B, Guenard F, Barbier O, Vohl MC. Effect of n-3 fatty acids on
the expression of inflammatory genes in THP-1 macrophages. Lipids Health
Dis. 2016;15:69.
3. Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate
cancer risk: a review of epidemiological and experimental evidence. Cancer
Causes Control. 2004;15:367–86.
4. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr. 2012;142:592S–9S.
5. Calder PC. n-3 fatty acids, inflammation and immunity: new mechanisms to
explain old actions. Proc Nutr Soc. 2013;72:326–36.
6. Flock MR, Harris WS, Kris-Etherton PM. Long-chain omega-3 fatty acids: time
to establish a dietary reference intake. Nutr Rev. 2013;71:692–707.
7. Gopinath B, Buyken AE, Flood VM, Empson M, Rochtchina E, Mitchell P.
Consumption of polyunsaturated fatty acids, fish, and nuts and risk of
inflammatory disease mortality. Am J Clin Nutr. 2011;93:1073–9.
8. Gorjao R, Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M,
Procopio J, Curi R. Comparative effects of DHA and EPA on cell function.
Pharmacol Ther. 2009;122:56–64.
9. Guerra I, Bermejo F. Biosimilars in inflammatory bowel disease:
management and care. Rev Esp Enferm Dig. 2015;107:389.
10. Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for
omega-3 index as a new risk factor. Pharmacol Res. 2007;55:217–23.
11. Honda KL, Lamon-Fava S, Matthan NR, Wu D, Lichtenstein AH. EPA and
DHA exposure alters the inflammatory response but not the surface
expression of Toll-like receptor 4 in macrophages. Lipids. 2015;50:121–9.
12. Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC,
Willett WC, Giovannucci EL. Dietary intake of n-3 and n-6 fatty acids and
the risk of prostate cancer. Am J Clin Nutr. 2004;80:204–16.
13. Lluis L, Taltavull N, Munoz-Cortes M, Sanchez-Martos V, Romeu M, Giralt M,
Molinar-Toribio E, Torres JL, Perez-Jimenez J, Pazos M, Mendez L, Gallardo JM,
Medina I, Nogues MR. Protective effect of the omega-3 polyunsaturated fatty
acids: eicosapentaenoic acid/docosahexaenoic acid 1:1 ratio on cardiovascular
disease risk markers in rats. Lipids Health Dis. 2013;12:140.
14. Lu J, Borthwick F, Hassanali Z, Wang Y, Mangat R, Ruth M, Shi D, Jaeschke A,
Russell JC, Field CJ, Proctor SD, Vine DF. Chronic dietary n-3 PUFA
intervention improves dyslipidaemia and subsequent cardiovascular
complications in the JCR:LA-cp rat model of the metabolic syndrome.
Br J Nutr. 2011;105:1572–82.
15. Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ. Docosahexaenoic acid but
not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate
in humans. Hypertension. 1999;34:253–60.
16. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect
of fish oil on heart rate in humans: a meta-analysis of randomized
controlled trials. Circulation. 2005;112:1945–52.
17. Mullen A, Loscher CE, Roche HM. Anti-inflammatory effects of EPA and DHA
are dependent upon time and dose-response elements associated with LPS
stimulation in THP-1-derived macrophages. J Nutr Biochem. 2010;21:444–50.
18. Oster RT, Tishinsky JM, Yuan Z, Robinson LE. Docosahexaenoic acid
increases cellular adiponectin mRNA and secreted adiponectin protein, as
well as PPARgamma mRNA, in 3T3-L1 adipocytes. Appl Physiol Nutr Metab.
2010;35:783–9.19. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N. Health benefits of n-3
polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic
acid. Adv Food Nutr Res. 2012;65:211–22.
20. Stark AK, Sriskantharajah S, Hessel EM, Okkenhaug K. PI3K inhibitors in
inflammation, autoimmunity and cancer. Curr Opin Pharmacol. 2015;23:82–91.
21. Tvrzicka E, Kremmyda LS, Stankova B, Zak A. Fatty acids as biocompounds:
their role in human metabolism, health and disease—a review. Part 1:
classification, dietary sources and biological functions.
BiomedPapMedFacUniv PalackyOlomoucCzechRepub. 2011;155:117–30.
22. Verlengia R, Gorjao R, Kanunfre CC, Bordin S, Martins De LT, Martins EF,
Curi R. Comparative effects of eicosapentaenoic acid and docosahexaenoic
acid on proliferation, cytokine production, and pleiotropic gene expression
in Jurkat cells. J Nutr Biochem. 2004;15:657–65.
23. Weylandt KH, Serini S, Chen YQ, Su HM, Lim K, Cittadini A, Calviello G.
Omega-3 polyunsaturated fatty acids: the way forward in times of mixed
evidence. Biomed Res Int. 2015;2015:143109.
24. Yaqoob P, Calder P. Effects of dietary lipid manipulation upon inflammatory
mediator production by murine macrophages. Cell Immunol. 1995;163:120–8.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
